GGrantIndex
Sort

53,477 grants matching addiction

GENETIC &ENVIRONMENT DETERMINANTS OF SMOKING CESSATION

$747,489
Virginia Commonwealth University · R01 · FY2002 · CA

Western States Node of the National Drug Abuse Treatment Clinical Trials Network

$747,413
Philip Todd Korthuis · Oregon Health & Science University · UG1 · FY2022 · DA

Supporting Treatment Access and Recovery through Linkage and Support (STAR-LS)

$747,382
David A Smelson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CE

Prescription Opioid Misuse: A Pharmacist-Led Intervention at Point of Service Efficacy Trial

$747,266
Gerald T. Cochran · University Of Utah · R01 · FY2021 · DA

GEMINI: Virtual Integrative Medical Group Visits for Managing Chronic Pain

$747,191
Niina M. Haas · Brightoutcome Inc. · R44 · FY2023 · AT

Clinical Trials Network: Pacific Northwest Node

$746,942
Dennis M Donovan · University Of Washington · UG1 · FY2019 · DA

Implementing a Multimodal Path to RecOVEry (IMPROVE): Primary and Secondary Prevention of Opioid Overdose in Acute Care

$746,821
Rachel Seymour · Carolinas Medical Center · R01 · FY2018 · CE

mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care

$746,806
Lillian Gelberg · University Of California Los Angeles · R01 · FY2022 · DA

Implementing a Multimodal Path to RecOVEry (IMPROVE): Primary and Secondary Prevention of Opioid Overdose in Acute Care

$746,769
Rachel Seymour · Carolinas Medical Center · R01 · FY2020 · CE

Southern Consortium Node of the Clinical Trials Network

$746,759
Kathleen Theresa Brady · Medical University Of South Carolina · UG1 · FY2024 · DA

A deep learning platform to evaluate the reliability of scientific claims by citation analysis.

$746,725
Josh Nicholson · Scite, Inc. · R44 · FY2020 · DA

Telemedicine for Smoking Cessation in Rural Primary Care

$746,702
Kimber P Richter · University Of Kansas Medical Center · R01 · FY2008 · HL

Development of a non-addictive analgesic targeting opioid receptor heteromers.

$746,689
Ajay S Yekkirala · Blue Therapeutics, Inc. · R44 · FY2016 · DA

Impact of Medical and Recreational Marijuana Laws On Cannabis, Opioids And Psychiatric Medications: National Study of VA Patients, 2000 - 2024

$746,412
Deborah S. Hasin · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2020 · DA

Impact of Medical and Recreational Marijuana Laws On Cannabis, Opioids And Psychiatric Medications: National Study of VA Patients, 2000 - 2024

$746,412
Deborah S. Hasin · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2023 · DA

Impact of Medical and Recreational Marijuana Laws On Cannabis, Opioids And Psychiatric Medications: National Study of VA Patients, 2000 - 2024

$746,412
Deborah S. Hasin · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2022 · DA

A STUDY OF ANESTHESIA-ASSISTED HEROIN DETOXIFICATION

$746,315
New York State Psychiatric Institute · R01 · FY2000 · DA

Rapid initiation of buprenorphine/naloxone to optimize MAT utilization in Philadelphia

$746,191
David S Metzger · University Of Pennsylvania · R01 · FY2019 · CE

The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network

$745,921
Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2019 · DA

Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes

$745,882
Thomas H. Brandon · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2017 · DA

(Epi)genetic Risk Architectures in Opioid Dependent Brain

$745,878
Peter Christopher Scacheri · Case Western Reserve University · R01 · FY2021 · DA

Mid Southern Primary Care Networks Node

$745,791
Li-Tzy T Wu · Duke University · UG1 · FY2018 · DA

Rapid initiation of buprenorphine/naloxone to optimize MAT utilization in Philadelphia

$745,547
David S Metzger · University Of Pennsylvania · R01 · FY2018 · CE

Mechanisms of pain and placebo analgesia

$745,520
Christian Grillon · National Center For Complementary & Integrative Health · ZIA · FY2012 · AT

National Drug Abuse Treatment Clinical Trials Network

$745,343
Walter Nmn Ling · University Of California Los Angeles · U10 · FY2010 · DA